P1 |
An
audit of the role of Sestimibi imaging of the parathyroid glands
in the management of parathyroid disease |
|
D Gable, J Bomanji & G Conway |
P2 |
Does
adrenal function influence bone status in primary hyperparathyroidism?
Preliminary results in a large series of patients at the time of
the diagnosis |
|
L Gianotti, F Tassone, A Pia, P Razzore,
F Cesario, G Magro & G Borretta |
P3 |
The
effect of local radiotherapy on osteoprotegerin levels in patients
with bone metastases |
|
A Abdulkhaliq, C Foo, G Baffoe, P Anand,
SI Girgis & C Quigley |
P4 |
Clinical
aspects of diabetic osteoarthropathy in type 1 and type 2 diabetes
mellitus patients |
|
AP Shepelkevich & DI Romeiko |
P5 |
Osteoporotic
fractures in old subjects: role of functional and nutritional status
and therapy effects during one year after fracture |
|
F Magri, V Valdes, V Guazzoni, M Cupri, L
Chiovato & E Ferrari |
P6 |
Circulating
osteoprotegerin and receptor activator of NF-kB ligand system in
patients with beta-thalassemia major |
|
N Angelopoulos, G Rombopoulos, D Kaltsas,
V Kaltzidou, E Katounda & G Tolis |
P7 |
The
role of genetic individuality and phytoestrogens with minerals
in prevention and treatment of postmenopausal osteoporosis |
|
I-O Vaasa, M Roosalu, S Teesalu & I Kalits |
P8 |
Is
there any combined influence of the N363S polymorphism in the glucocorticoid
receptor gene and the BsmI polymorphism in the vitamin D receptor
gene on the occurrence of glucocorticoid-induced osteoporosis in
patients with bronchial asthma? |
|
U Tworowska, B Bidzinska-Speichert, A Obojski,
M Demissie, JW Koper & R Slezak |
P9 |
Bone
mineral density in patients with type 1 diabetes |
|
E Giorgadze, M Tsagareli, N Jikurauli & N
Svani |
P10 |
Thyroid
hormone receptor alpha has a critical negative role in maintenance
of the adult skeleton |
|
JHD Bassett, PJ O'Shea, A Boyde, PGT Howell,
J Samarut, O Chassande & GR Williams |
P11 |
PTH
and phosphate circadian rhythms are altered in adult growth hormone
deficient patients with low bone mineral density |
|
HD White, AM Ahmad, BH Durham, WD Fraser & JP
Vora |
P12 |
Oral
phosphate therapy used as an adjunct to growth hormone in adult
growth hormone deficiency results in greater changes in bone mineral
density compared with growth hormone replacement alone |
|
HD White, AM Ahmad, BH Durham, WD Fraser & JP
Vora |
P13 |
Polymorphism
in farnesyl pyrophosphatesynthase (FDPS) gene and relation with
BMD and response to aminobisphosphonate treatment |
|
S Silvestri, S Carbonell, AB Thomsen, Y Bagger,
C Christiansen & ML Brandi |
P14 |
Do
different generations of PTH assay induce different diagnosis in
renal bone disease? |
|
A Gendrot, A Georges, C Lasseur, L Bordenave & J-B
Corcuff |
P15 |
Management
of primary hyperparathyroidism - are we following consensus guidelines? |
|
KK Gangopadhyay, A Gurubili, D Nair & P
De |
P16 |
Value
of qualitative bone histology assessment in the evaluation of subjects
with primary osteoporosis |
|
CE Georgescu, T Seck, HW Minne, R Ziegler,
I Duncea, L Gozariu & J Pfeilschifter |
P17 |
Hearing
impairment increases risk of bone fractures in women with Turner's
syndrome |
|
TS Han, GS Conway & B Cadge |
P18 |
Evaluation
of bone mineral density and markers of bone turnover in haemodialysis
patients |
|
A Zygmunt, I Kurnatowska, J Fijalkowska-
Morawska, J Bialkowska, M Jablkowski, M Nowicki & A Lewinski |
P19 |
The
effect of ceramide on IGF-I induced proliferation in growth plate
chondrocytes |
|
VE MacRae, SF Ahmed & C Farquharson |
P20 |
Treatment
and follow-up of primary hyperparathyroidism: 50 cases |
|
H Cheikhrouhou, I Hadj Ali, K Khiari & N
Ben Abdallah |
P21 |
Is
there any relationship between the BsmI and FokI polymorphisms
in the vitamin D receptor gene and bone mineral density in men? |
|
J Kuliczkowska-Płaksej, A Trzmiel, A
Filus, U Tworowska, D Jedrzejuk & A Milewicz |
P22 |
Mutational
analysis of the PHEX gene in familial and sporadic cases of X-linked
hypophosphatemia (XLH) |
|
S Clausmeyer, PC Clemens, E Schulze & F
Raue |
P23 |
The
reduction of bone mineral density in post-menopausal women with
primary hyperparathyroidism is higher in the presence of concomitant
GH hormone secretion impairment |
|
E Cecconi, M Genovesi, F Bogazzi, L Grasso,
M Procopio, C Marcocci, A Pinchera, L Bartalena, E Martino & M
Gasperi |
P24 |
Effect
of melatonin on gene expression and mineralization in mouse osteoblast
culture |
|
D Manda, C Busu, O Ianas, G Stefanovici,
R Calarasu, D Grigorie & C Dumitrache |
P25 |
Effects
of growth hormone administration on parathyroid hormone sensitivity
and bone mineral metabolism in established osteoporosis |
|
F Joseph, A Ahmad, HD White, A Joshi, B Durham,
S Vinjamuri, K Ashawesh, WD Fraser & JP Vora |
P26 |
Is
1g of calcium and 800IU of vitamin D sufficient to replenish vitamin
D stores in postmenopausal women with low bone density? |
|
T Sathyapalan, M Bottazzi, C Walton & P
Albertazzi |
P27 |
Synergistic
induction of osteoblastic local glucocorticoid metabolism by inflammatory
cytokines and glucocorticoids: a novel mechanism for glucocorticoid-induced
bone disease |
|
K Kaur, R Hardy, PM Stewart, EH Rabbitt,
M Hewison & MS Cooper |
P28 |
Evidence
for high prevalence of hormonal irregularities in male osteoporosis |
|
S Goebel, C Riegel, L Seefried, B Saller & F
Jakob |
P29 |
Evaluation
of bone markers and structure in subclinical Cushing's syndrome |
|
M Monesi, MR Ambrosio, S Taroni, M Bondanelli,
MC Zatelli & EC degli Uberti |
P30 |
Asymptomatic
primary hyperparathyroidism: preliminary results of a prospective
randomized study on the effect of parathyroidectomy |
|
E Ambrogini, L Cianferotti, E Vignali, F
Cetani, G Viccica, A Picone, P Miccoli, A Pinchera & C Marcocci |
P31 |
Brown
tumors in a patient with gluten enteropathy and masked primary
(or tertiary) hyperparathyroidism |
|
K Jacob, J Sudagani, M Davies & P Selby |
P32 |
Baseline
characteristics of postmenopausal Greek women with osteoporosis
who had an inadequate response to antiresorptive medications |
|
A Ginis, E Charalampidou & N Thalassinos
and the Hellenic OSSO Study Group |
P33 |
Effect
of grape procyanidins on TNF alpha mRNA expression and cell DNA
damage in MC3T3-E1 osteoblast-like cells |
|
in vitro JY Zhong & LH Zhang |
P34 |
The
effects of dexamethasone and dehydroepiandrosterone (DHEA) on cytokines
and receptor expression in a human osteoblastic cell line: potential
steroid-sparing role for DHEA |
|
G Harding, YT Mak, B Evans, J Cheung, D MacDonald & G
Hampson |
P35 |
Assessment
of bone health and body composition in Glasgow school children |
|
R Rashid & SF Ahmed |
P36 |
Assessment
of bone mineral density (BMD) in patients with adrenal incidentaloma
(AI): comparison between dual-energy X-ray absorptiometry (DEXA)
and quantitative ultrasonometry (QUS) |
|
G Reimondo, S Bovio, M Ventura, G Osella,
A Angeli & M Terzolo |
P37 |
A
comparative study of neck ultrasonography, Sestamibi scan and parathyroid
surgery findings |
|
KCS Dixit, AJ Norris, PG Wiles, MW Savage,
AN Khan & A Gandhi |
P38 |
Glucocorticoid
metabolism in mouse osteoblasts: a model for the effects of local
glucocorticoid generation on bone |
|
R Crook, K Hewitt, PM Stewart, EH Rabbitt & MS
Cooper |
P39 |
Long-term
growth hormone (GH) replacement in GH deficient adults - favourable
effect on bone and body composition |
|
V Hána, J Cáp, T Vas¢átko & JJ
Stepán |
P40 |
Does
parathyroidectomy reduce the risk of fractures and renal stones?
Results of a systematic review and meta analysis |
|
BE Sanders, M Davies & PL Selby |
P41 |
Brown
tumors in hyperparathyroidism may be mistaken for primitive bone
neoplasia: report of two cases |
|
CA Rota, F Ingraudo, RM Paragliola, MP Ricciato,
AL Bilotta, F Ianni, F Gallo, G Ubertini, SM Corsello & A Pontecorvi |
P42 |
The
effect of once-weekly risedronate on biochemical markers of bone
turnover after three months of treatment |
|
D Paun, D Grigorie, A Ghemigian, F Cofaru & C
Dumitrache |
P43 |
Quantitative
ultrasound at the hand phalanges in patients with acromegaly |
|
M Bolanowski, W Pluskiewicz & J Daroszewski |
P44 |
Selenium
supplementation restores the antioxidative capacity and prevents
cell damage in mesenchymal stem cells |
|
in vitro R Ebert, M Ulmer, S Zeck, J Meissner-Weigl,
D Schneider, H Stopper, N Schupp, M Kassem & F Jakob |
P45 |
Expression
of the membrane-associated hormone-sensitive protein UO-44 in hMSCTERT
immortalized mesenchymal stem cells |
|
L Seefried, R Ebert, M Kassem & F Jakob |
P46 |
The
effect of once-weekly risedronate on biochemical markers of bone
turnover after three months of treatment |
|
D Paun, D Grigorie, A Ghemigian, F Cofaru & C
Dumitrache |
